We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.83B
AUM Growth
+$102M
Cap. Flow
+$35.3M
Cap. Flow %
1.25%
Top 10 Hldgs %
39.65%
Holding
489
New
23
Increased
128
Reduced
177
Closed
18

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$15.5M
2
NFLX icon
Netflix
NFLX
+$7.19M
3
ABT icon
Abbott
ABT
+$5.87M
4
PYPL icon
PayPal
PYPL
+$5.83M
5
UBER icon
Uber
UBER
+$5.57M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$5.68M
2
FCX icon
Freeport-McMoran
FCX
+$5.64M
3
C icon
Citigroup
C
+$4.04M
4
WK icon
Workiva
WK
+$2.79M
5
JCI icon
Johnson Controls International
JCI
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 19.83%
2 Energy 16.4%
3 Technology 13.36%
4 Financials 11.77%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
276
Enterprise Products Partners
EPD
$82.6B
$557K 0.02%
14,728
RH icon
277
RH
RH
$3.56B
$552K 0.02%
3,950
STX icon
278
Seagate
STX
$178B
$550K 0.02%
1,405
+55
+4% +$21K
EPRX
279
Eupraxia Pharmaceuticals
EPRX
$431M
$548K 0.02%
75,650
-1,750
-2% -$14.1K
COPY
280
Tweedy Browne Insider + Value ETF
COPY
$353M
$548K 0.02%
39,947
+12,854
+47% +$177K
AMCR icon
281
Amcor
AMCR
$20.3B
$546K 0.02%
13,745
-64
-0.5% -$2.83K
RIO icon
282
Rio Tinto
RIO
$147B
$544K 0.02%
5,836
ROST icon
283
Ross Stores
ROST
$74.9B
$542K 0.02%
2,500
TMO icon
284
Thermo Fisher Scientific
TMO
$198B
$537K 0.02%
1,093
-1,886
-63% -$1.02M
ECG
285
Everus Construction Group
ECG
$6.8B
$537K 0.02%
4,548
WFC.PRL icon
286
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.72B
$527K 0.02%
456
-3
-0.7% -$3.65K
TPR icon
287
Tapestry
TPR
$28.6B
$526K 0.02%
3,729
-61
-2% -$8.65K
VIS icon
288
Vanguard Industrials ETF
VIS
$8.12B
$524K 0.02%
1,679
-22
-1% -$7.14K
AON icon
289
Aon
AON
$78.4B
$515K 0.02%
1,595
+467
+41% +$155K
SHY icon
290
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$510K 0.02%
6,175
CTVA icon
291
Corteva
CTVA
$58.4B
$508K 0.02%
6,068
+1,231
+25% +$92.7K
XBI icon
292
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$506K 0.02%
3,964
-2
-0.1% -$250
APTV icon
293
Aptiv
APTV
$12.2B
$505K 0.02%
7,278
-5,027
-41% -$387K
TRI icon
294
Thomson Reuters
TRI
$42B
$504K 0.02%
5,515
AAP icon
295
Advance Auto Parts
AAP
$3.21B
$500K 0.02%
9,478
GNRC icon
296
Generac Holdings
GNRC
$12.7B
$489K 0.02%
2,504
BUI icon
297
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$740M
$485K 0.02%
18,400
+10,000
+119% +$275K
CDZI icon
298
Cadiz
CDZI
$286M
$484K 0.02%
98,600
HSY icon
299
Hershey
HSY
$34.8B
$479K 0.02%
2,303
B
300
Barrick Mining
B
$58.5B
$478K 0.02%
11,730

Similar funds

Ingalls & Snyder LLC's Q1 2026 Portfolio in Review

As of Q1 2026, Ingalls & Snyder LLC held 489 positions worth $2.83B, up 3.8% from $2.72B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ingalls & Snyder LLC's Q1 2026 filing shows 23 new, 128 increased, 177 reduced and 18 closed positions. Its largest new stake was iShares MSCI Japan Small-Cap ETF: 7,904 shares worth $767K. The largest sale was FTAI Aviation, an estimated $5.68M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2026 buy was iShares MSCI Japan Small-Cap ETF: 7,904 shares worth $767K.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q1 2026, an estimated $15.5M increase.
  • Ingalls & Snyder LLC's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $5.68M.
  • Ingalls & Snyder LLC fully exited New Gold Inc in Q1 2026, selling an estimated $457K.
  • Ingalls & Snyder LLC's ten largest holdings make up 40% of its $2.83B portfolio in Q1 2026.
  • Ingalls & Snyder LLC opened 23 new positions and closed 18 in Q1 2026.
  • Ingalls & Snyder LLC's portfolio value rose 3.8% quarter-over-quarter to $2.83B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.